The U.S Food and Drug Administration has approved Provention Bio’s teplizumab for people at risk of T1D in the U.S.
November 14 is World Diabetes Day, when we come together to raise awareness of diabetes and how it affects millions of people around the globe. The International Diabetes Foundation sets the annual theme, and, like last year, 2022 is all about increasing access to diabetes education, with the slogan ‘education to protect tomorrow’. So what […]
Minister for Health and Aged Care, The Hon Mark Butler, has today announced that the next generation of Omnipod insulin pumps will be subsidised from December 1.
The T1D Index is a first-of-its-kind data simulation tool that measures the human and public health impact of the T1D crisis in every country across the globe.
JDRF Australia are delighted to announce that much-loved sports host and TV presenter, James Bracey, has today joined the organisation as an ambassador to lend his support to the organisation’s goal of a world without type 1 diabetes (T1D). Mr. Bracey is well known for his journalism with the Nine Network which he joined in […]
Did you know that four out of every five people living with diabetes have experienced stigma? A 2021 study by the Australian Centre for Behavioural Research in Diabetes found that more than 80% of people with diabetes “have been judged, blamed, shamed, or treated differently due to their diabetes”. This can, in turn, often lead […]
We are excited to announce the launch of our brand new teen wellbeing guide, Testing Times, designed to help teenagers manage their type 1 diabetes (T1D) while staying on top of studying, socialising and the changes that come with transitioning into adulthood. The guide was created with the knowledge and expertise of T1D healthcare clinicians. […]
The campaign for increased access to continuous glucose monitoring devices (CGMs) for the T1D community has been a long and winding road. 6 years ago, there was no government reimbursement for CGMs at all. Thanks to consistent advocacy and campaigning from leading diabetes organisations, the landscape has changed significantly– transforming the lives of many people […]
Coalition commitment of $273.1M will make technology access a reality for 130,000 Australians living with T1D. JDRF, Australia’s largest organisation dedicated to T1D research and advocacy, welcomes the significant commitment to T1D technology access announced today by Prime Minister Scott Morrison. Currently, many people lose access to this technology, which is shown to improve short- […]
JDRF International will provide financial support for Civica Inc. to manufacture and distribute low-cost insulin.
Clive Pack and Ann Roberts were instrumental in the initiation and growth of JDRF Australia for many of its early years.
MP meetings are a core part of JDRF advocacy, and this month we chatted with Michelle Landry MP on why she values JDRF advocate meetings.
I joined the JDRF Government Leadership Group to educate Australian government and public on type 1 diabetes and improve access to technology.
Dr Izzy Smith specialises in endocrinology and we spoke to her for some guidance on Covid-19 for people living with type 1 diabetes.
This week, new results published in the journal Microbiome showed that a six-week food supplement for people with T1D resulted in changes to bacteria in the gut and a strengthened immune system. The results are from a clinical trial funded through JDRF’s Type 1 Diabetes Clinical Research Network (T1DCRN) and Macquarie Group Foundation Future Research […]
Friday, January 14, 2022 JDRF and other diabetes organisations have welcomed the Federal Government’s announcement of $10 million over four years to establish the Australian Centre for Accelerating Diabetes Innovations (ACADI) at the University of Melbourne. The Centre will help turn vital medical research into better prevention, diagnosis and treatment for patients with all types of diabetes. The funding will be delivered through the […]
JDRF Australia today announced a new partnership with Insulet Corporation Australia, an innovative medical device company, in a joint move to improve outcomes for the type one diabetes (T1D) community. Insulet is part of a global network dedicated to making the lives of people with diabetes and other conditions easier through technology like its Omnipod DASH Insulin management system, which offer new alternatives for administering insulin. Its partnership with JDRF will focus on […]
An analysis of the impact of the Australian Government’s continuous glucose monitoring (CGM) subsidy scheme for people aged under 21 has recently been published in the journal Diabetes Care. Led by Prof Tim Jones and the Australasian Diabetes Data Network (ADDN) Study Group, the study found that those who registered for the subsidy had significant […]